Fund moves

Repligen (RGEN): DF Dent & Co Inc reduced its stake -130K shares

DF Dent & Co Inc reduced its stake in Repligen, per its Q1 2026 13F.

365K
Shares reported · -130K vs prior quarter
0.82%
Disclosed portfolio weight
$43M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

What stands out in this filing

  • 495,550 shares in Q4 2025, 365,115 now (−26.3% in share count).
  • Reported at $43M, 0.82% of the portfolio value in this 13F filing.
  • 10 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 21, 2026InsiderCEO sold ~$536K of RGEN shares in the open market
  2. May 5, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. May 28, 2026Federal contract · $175K obligatedDepartment of Health and Human Services awarded REPLIGEN CORP: $175K obligated to date
  2. Jun 25, 2026InsiderCFO sold ~$106K of RGEN shares in the open market
  3. Jul 16, 2026InsiderCFO sold ~$80K of RGEN shares in the open market
  4. Jul 21, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
  5. Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
  6. Aug 20, 2026InsiderCEO sold ~$977K of RGEN shares in the open market
  7. Sep 4, 2026InsiderCEO sold ~$504K of RGEN shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Repligen

For Repligen, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RGEN page.

How this filing works

Explore the data

Common questions

What does this filing report about Repligen (RGEN) stock?

DF Dent & Co Inc reduced its stake in Repligen, per its Q1 2026 13F. Now 365K shares, $43M reported value, 0.82% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 15, 2026.

What stands out in this filing?

495,550 shares in Q4 2025, 365,115 now (−26.3% in share count). Reported at $43M, 0.82% of the portfolio value in this 13F filing. 10 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Repligen recently?

For Repligen, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the RGEN page.

Does this mean RGEN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Repligen

Everything OQRO holds on this company is on its RGEN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data